Skip to Main Content

Paper Details

Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
Sci Transl Med
63
2018
B cell lymphoma 2, BCL-2, BCL-2 homology domain 3, GSK-J4, H3K27, High, High-risk neuroblastoma, JMJD3, MYCN, MYCN-amplified neuroblastoma, PUMA, Retinoic acid, Retinoic acid (RA)-resistant neuroblastoma cells, UTX, antineuroblastoma, demethylases, high-risk neuroblastoma, histone, histone 3, histone H3K27, histone demethylase Jumonji D3, lysine, neuroblastoma, neuroblastoma cells, neuroblastomas, p53, patient-derived xenograft models, tumor, tumor cell line panel, tumors, ubiquitously transcribed tetratricopeptide repeat, X chromosome, venetoclax
Author NameAffiliation
Mikhail G DozmorovVirginia Commonwealth University
Charles Patrick ReynoldsCancer Center, Texas Tech University Health Sciences Center School of Medicine
Cyril H BenesCenter for Cancer Research, Massachusetts General Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2